Top Articles

January 9, 2017 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

December 27 was the 100th birthday of pathologist Jan Steiner, MD, FRCP (C), FCAP, remembered by many long-serving lab executives and clinical pathologists as one of the co-founders, along with James Root, PhD, of Chi Laboratory Systems in the late 1980s. This was a time when he was already in his 70s. He worked with Chi

Read More

China Invests $9 Billion In Precision Medicine

United States is undisputed leader in use of genomics, but China wants to catch up

CEO SUMMARY: In the 1960s, it was a race to be first in space between the United States and the Soviet Union. This decade, it’s a race to be first in genetic and precision medicine between the U.S. and China. To that end, the Chinese government has budgeted $9 billion as an investment to further

Read More

Legal Update NJ Lab Sues to Challenge Payers About Its Out-of-Network Status

MDL sues Independence Blue Cross of Philadelphia and LabCorp over exclusion as network provider

ONE WAY THAT A CLINICAL LAB can fight back against insurers who refuse to pay lab test claims is to sue them. That’s exactly what Medical Diagnostic Laboratories of Hamilton, N.J. is doing!

Not only has MDL filed lawsuits against two major health insurance companies, but in one lawsuit, it named a national lab company as

Read More

In Texas, Questions for UnitedHealth, BeaconLBS

Pathologists ask: How does this improve quality? How will we get reimbursed for IHC test claims?

CEO SUMMARY: As of January 1, 2017, clinical laboratories and pathology groups in Texas will find it more difficult to serve the 500,000 patients enrolled in UnitedHealthcare’s fully-insured commercial plans in the Lone Star State. That’s because—just as it did in Florida—UnitedHealthcare, with its partners BeaconLBS and Laboratory Corporation of America, is implementing its laboratory

Read More

Lab Market Update Theranos Lays Off More Staff, Voids More Lab Test Results

Once again, a stream of bad news about problems puts beleaguered lab firm in the national headlines

ONCE AGAIN, the controversial lab testing company, Theranos, Inc., found itself the subject of negative news stories. In recent weeks, The Wall Street Journal reported that the beleaguered lab testing company in Palo Alto, Calif., laid off 155 staffers, voided more laboratory test results, and cut ties with its high-profile lawyer.

This round of bad news

Read More

PAMA Economics Drives Merger Of Two Seattle-Area Pathology Groups

Seattle pathologists see the need to be better positioned when CMS slashes reimbursement

CEO SUMMARY: Among the three chief reasons for the merger of CellNetix and Puget Sound Institute of Pathology, the most compelling was the need to address the challenges in the current reimbursement environment and to prepare for reductions in payment to pathologists expected in the coming years under the Patient Access to Medicare Act. CellNetix

Read More

$26 Million Recoupment from Medicare Audit Hammers Pharmacogenomic Lab

Lab hit with $26 million overpayment demand after ZPIC auditor denies 100% of sampled claims

CEO SUMMARY: After Pharmacogenetics Diagnostic Laboratory LLC was audited by a Medicare Zone Program Integrity Contractor (ZPIC), it faced a $26 million repayment demand. The lab company appealed and asked for a redetermination, then filed for Chapter 11 bankruptcy protection. These developments should be a concern to all labs offering pharmacogenomic testing to Medicare patients.

Read More

Is Pharmacogenomics Testing Unaffordable for Payers?

ACROSS THE UNITED STATES, labs that perform pharmacogenomic tests complain that both government and private payers are reluctant to issue coverage guidelines and adequate reimbursement for these assays. Yet, this new class of diagnostic lab tests is the foundation of personalized and precision medicine.

Why are government and private health programs taking this tough stand on

Read More

Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

The Dark Report

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

Get digital (web + tablet) and print editions of The Dark Report for only $22.97 per week.
Get web and tablet access of The Dark Report for only $19.12 per week.
Get a hard copy of The Dark Report delivered to your home for only $15.27 per week.
Enter Your Login Credentials